schliessen

Filtern

 

Bibliotheken

Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.(Report)

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S0140-6736(17)30397-5 Byline: Francesco Costa (a)(b)(d), David van Klaveren (b)(c), Stefan James (e), Dik Heg (f), Lorenz Raber (a), Fausto Feres (g), Thomas Pilgrim (a), Myeong-Ki Hong (l), Hyo-Soo Kim (h), Ant... Full description

Journal Title: The Lancet March 11, 2017, Vol.389(10073), p.1025(10)
Main Author: Costa, Francesco
Other Authors: Van Klaveren, David , James, Stefan , Heg, Dik , Raaaaaeanber, Lore , Feres, Fausto , Pilgrim, Thomas , Hong, Myeong - Ki , Kim, Hyo - Soo , Colombo, Antonio , Steg, Philippe Gabriel , Zanchin, Thomas , Palmerini, Tullio , Wallentin, Lars , Bhatt, Deepak L , Stone, Gregg W , Windecker, Stephan , Steyerberg, Ewout W , Valgimigli, Marco,
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: ISSN: 0140-6736 ; DOI: 10.1016/S0140-6736(17)30397-5
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: gale_hrca485320798
title: Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.(Report)
format: Article
creator:
  • Costa, Francesco
  • Van Klaveren, David
  • James, Stefan
  • Heg, Dik
  • Raaaaaeanber, Lore
  • Feres, Fausto
  • Pilgrim, Thomas
  • Hong, Myeong - Ki
  • Kim, Hyo - Soo
  • Colombo, Antonio
  • Steg, Philippe Gabriel
  • Zanchin, Thomas
  • Palmerini, Tullio
  • Wallentin, Lars
  • Bhatt, Deepak L
  • Stone, Gregg W
  • Windecker, Stephan
  • Steyerberg, Ewout W
  • Valgimigli, Marco
subjects:
  • Aspirin -- Complications And Side Effects
  • Stents
  • Clinical Trials
  • Preventive Medicine
  • Cardiology
  • Medical Research
  • Medical Schools
  • Health Policy
ispartof: The Lancet, March 11, 2017, Vol.389(10073), p.1025(10)
description: To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S0140-6736(17)30397-5 Byline: Francesco Costa (a)(b)(d), David van Klaveren (b)(c), Stefan James (e), Dik Heg (f), Lorenz Raber (a), Fausto Feres (g), Thomas Pilgrim (a), Myeong-Ki Hong (l), Hyo-Soo Kim (h), Antonio Colombo (i)(j), Philippe Gabriel Steg (k), Thomas Zanchin (a), Tullio Palmerini (m), Lars Wallentin (e), Deepak L Bhatt (n), Gregg W Stone (o), Stephan Windecker (a), Ewout W Steyerberg (b), Marco Valgimigli (a)(b) Abstract: Dual antiplatelet therapy (DAPT) with aspirin plus a P2Y.sub.12 inhibitor prevents ischaemic events after coronary stenting, but increases bleeding. Guidelines support weighting bleeding risk before the selection of treatment duration, but no standardised tool exists for this purpose. Author Affiliation: (a) Swiss Cardiovascular Center Bern, Bern University Hospital, Bern, Switzerland (b) Erasmus University Medical Center, Rotterdam, Netherlands (c) Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA (d) Department of Clinical and Experimental Medicine, Policlinic "G Martino", University of Messina, Messina, Italy (e) Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden (f) Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland (g) Istituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil (h) Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea (i) EMO-GVM Centro Cuore Columbus, Milan, Italy (j) Interventional Cardiology Department, San Raffaele Scientific Institute, Milan, Italy (k) Department of Cardiology, Assistance Publique-Hopitaux de Paris (AP-HP), Bichat Hospital, Paris, France (l) Severance Cardiovascular Hospital, Yonsei University College of Medicine and Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea (m) Dipartimento Cardio-Toraco-Vascolare, University of Bologna, Bologna, Italy (n) Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, MA, USA (o) Columbia University Medical Center/New York-Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY, USA
language: English
source:
identifier: ISSN: 0140-6736 ; DOI: 10.1016/S0140-6736(17)30397-5
fulltext: fulltext
issn:
  • 0140-6736
  • 01406736
url: Link


@attributes
ID1510489862
RANK0.06999999
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid485320798
sourceidgale_hrca
recordidTN_gale_hrca485320798
sourceformatXML
sourcesystemPC
pqid1877527567
galeid485320798
display
typearticle
titleDerivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.(Report)
ispartofThe Lancet, March 11, 2017, Vol.389(10073), p.1025(10)
identifierISSN: 0140-6736 ; DOI: 10.1016/S0140-6736(17)30397-5
subjectAspirin -- Complications And Side Effects ; Stents ; Clinical Trials ; Preventive Medicine ; Cardiology ; Medical Research ; Medical Schools ; Health Policy
descriptionTo link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S0140-6736(17)30397-5 Byline: Francesco Costa (a)(b)(d), David van Klaveren (b)(c), Stefan James (e), Dik Heg (f), Lorenz Raber (a), Fausto Feres (g), Thomas Pilgrim (a), Myeong-Ki Hong (l), Hyo-Soo Kim (h), Antonio Colombo (i)(j), Philippe Gabriel Steg (k), Thomas Zanchin (a), Tullio Palmerini (m), Lars Wallentin (e), Deepak L Bhatt (n), Gregg W Stone (o), Stephan Windecker (a), Ewout W Steyerberg (b), Marco Valgimigli (a)(b) Abstract: Dual antiplatelet therapy (DAPT) with aspirin plus a P2Y.sub.12 inhibitor prevents ischaemic events after coronary stenting, but increases bleeding. Guidelines support weighting bleeding risk before the selection of treatment duration, but no standardised tool exists for this purpose. Author Affiliation: (a) Swiss Cardiovascular Center Bern, Bern University Hospital, Bern, Switzerland (b) Erasmus University Medical Center, Rotterdam, Netherlands (c) Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA (d) Department of Clinical and Experimental Medicine, Policlinic "G Martino", University of Messina, Messina, Italy (e) Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden (f) Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland (g) Istituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil (h) Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea (i) EMO-GVM Centro Cuore Columbus, Milan, Italy (j) Interventional Cardiology Department, San Raffaele Scientific Institute, Milan, Italy (k) Department of Cardiology, Assistance Publique-Hopitaux de Paris (AP-HP), Bichat Hospital, Paris, France (l) Severance Cardiovascular Hospital, Yonsei University College of Medicine and Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea (m) Dipartimento Cardio-Toraco-Vascolare, University of Bologna, Bologna, Italy (n) Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, MA, USA (o) Columbia University Medical Center/New York-Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY, USA
languageEnglish
source
creatorCosta, Francesco ; Van Klaveren, David ; James, Stefan ; Heg, Dik ; Raaaaaeanber, Lore ; Feres, Fausto ; Pilgrim, Thomas ; Hong, Myeong - Ki ; Kim, Hyo - Soo ; Colombo, Antonio ; Steg, Philippe Gabriel ; Zanchin, Thomas ; Palmerini, Tullio ; Wallentin, Lars ; Bhatt, Deepak L ; Stone, Gregg W ; Windecker, Stephan ; Steyerberg, Ewout W ; Valgimigli, Marco;
version10
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
search
titleDerivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.(Report)
descriptionTo link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S0140-6736(17)30397-5 Byline: Francesco Costa (a)(b)(d), David van Klaveren (b)(c), Stefan James (e), Dik Heg (f), Lorenz Raber (a), Fausto Feres (g), Thomas Pilgrim (a), Myeong-Ki Hong (l), Hyo-Soo Kim (h), Antonio Colombo (i)(j), Philippe Gabriel Steg (k), Thomas Zanchin (a), Tullio Palmerini (m), Lars Wallentin (e), Deepak L Bhatt (n), Gregg W Stone (o), Stephan Windecker (a), Ewout W Steyerberg (b), Marco Valgimigli (a)(b) Abstract: Dual antiplatelet therapy (DAPT) with aspirin plus a P2Y.sub.12 inhibitor prevents ischaemic events after coronary stenting, but increases bleeding. Guidelines support weighting bleeding risk before the selection of treatment duration, but no standardised tool exists for this purpose. Author Affiliation: (a) Swiss Cardiovascular Center Bern, Bern University Hospital, Bern, Switzerland (b) Erasmus University Medical Center, Rotterdam, Netherlands (c) Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA (d) Department of Clinical and Experimental Medicine, Policlinic "G Martino", University of Messina, Messina, Italy (e) Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden (f) Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland (g) Istituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil (h) Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea (i) EMO-GVM Centro Cuore Columbus, Milan, Italy (j) Interventional Cardiology Department, San Raffaele Scientific Institute, Milan, Italy (k) Department of Cardiology, Assistance Publique-Hopitaux de Paris (AP-HP), Bichat Hospital, Paris, France (l) Severance Cardiovascular Hospital, Yonsei University College of Medicine and Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea (m) Dipartimento Cardio-Toraco-Vascolare, University of Bologna, Bologna, Italy (n) Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, MA, USA (o) Columbia University Medical Center/New York-Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY, USA
subject
0Aspirin--Complications and side effects
12833
22834
3Medicinals and botanicals
4Pharmaceutical preparations
5Pharmaceutical Preparation Manufacturing
6Administration of Public Health Programs
7Research and Development in Biotechnology
8325412
9923120
10541711
11France
124EUFR
13Stent (Surgery)
14Clinical trials
15Medicine, Preventive
16Preventive health services
17Cardiology
18Medical research
19Medicine, Experimental
20Medical policy
general
0English
1Elsevier B.V.
2Cengage Learning, Inc.
sourceidgale_hrca
recordidgale_hrca485320798
issn
00140-6736
101406736
rsrctypearticle
creationdate2017
recordtypearticle
addtitleThe Lancet
searchscopegale_hrca
scopegale_hrca
lsr30VSR-Enriched:[pages, galeid, eissn, pqid, creator]
sort
titleDerivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.(Report)
creationdate20170311
facets
frbrgroupid7760132097222464386
frbrtype5
newrecords20170321
languageeng
creationdate2017
topic
0Aspirin–Complications And Side Effects
1Stents
2Clinical Trials
3Preventive Medicine
4Cardiology
5Medical Research
6Medical Schools
7Health Policy
collectionHealth Reference Center Academic (Gale)
prefilterarticles
rsrctypearticles
jtitleLancet
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
atitleDerivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials
jtitleThe Lancet
risdate20170311
volume389
issue10073
spage1025
issn0140-6736
genrearticle
ristypeJOUR
abstractTo link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S0140-6736(17)30397-5 Byline: Francesco Costa (a)(b)(d), David van Klaveren (b)(c), Stefan James (e), Dik Heg (f), Lorenz Raber (a), Fausto Feres (g), Thomas Pilgrim (a), Myeong-Ki Hong (l), Hyo-Soo Kim (h), Antonio Colombo (i)(j), Philippe Gabriel Steg (k), Thomas Zanchin (a), Tullio Palmerini (m), Lars Wallentin (e), Deepak L Bhatt (n), Gregg W Stone (o), Stephan Windecker (a), Ewout W Steyerberg (b), Marco Valgimigli (a)(b) Abstract: Dual antiplatelet therapy (DAPT) with aspirin plus a P2Y.sub.12 inhibitor prevents ischaemic events after coronary stenting, but increases bleeding. Guidelines support weighting bleeding risk before the selection of treatment duration, but no standardised tool exists for this purpose. Author Affiliation: (a) Swiss Cardiovascular Center Bern, Bern University Hospital, Bern, Switzerland (b) Erasmus University Medical Center, Rotterdam, Netherlands (c) Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA (d) Department of Clinical and Experimental Medicine, Policlinic "G Martino", University of Messina, Messina, Italy (e) Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden (f) Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland (g) Istituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil (h) Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea (i) EMO-GVM Centro Cuore Columbus, Milan, Italy (j) Interventional Cardiology Department, San Raffaele Scientific Institute, Milan, Italy (k) Department of Cardiology, Assistance Publique-Hopitaux de Paris (AP-HP), Bichat Hospital, Paris, France (l) Severance Cardiovascular Hospital, Yonsei University College of Medicine and Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea (m) Dipartimento Cardio-Toraco-Vascolare, University of Bologna, Bologna, Italy (n) Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, MA, USA (o) Columbia University Medical Center/New York-Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY, USA
pubElsevier B.V.
doi10.1016/S0140-6736(17)30397-5
lad01gale_hrca
pages1025-1034
eissn1474547X
date2017-03-11